HLB Therapeutics Co (XKRX:115450) YoY EBITDA Growth : 1,272.08% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. HLB Therapeutics Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 1,272.08%.

HLB Therapeutics Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩29.60.

HLB Therapeutics Co YoY EBITDA Growth Historical Data

The historical data trend for HLB Therapeutics Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co YoY EBITDA Growth Chart

HLB Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-368.92

18.11

-11.67

70.90

227.92

HLB Therapeutics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															51.03	6,077.06	748.51	61.12	1,272.08

HLB Therapeutics Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

HLB Therapeutics Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(94.847	-	-74.148)	/	\| -74.148 \|
=	227.92 %

HLB Therapeutics Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(29.595	-	-2.525)	/	\| -2.525 \|
=	1,272.08 %

HLB Therapeutics Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Therapeutics Co (XKRX:115450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines